CORRECTUMUNDO BB! Will this submission unlock the starting of the other longtime “planned” trials one by one or does the FDA NDA submission still push this out?
My thinking is, similiar to the AD trial data, the goal is to use genomic sequencing in all disease trials to provide proof a) the drug is actually working and b) you actually have the disease.
That Partex partnership is going to a key piece in the overall puzzle imo. “Unleash the hounds!”